These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31656939)

  • 21. The off-pump technique in redo coronary artery bypass grafting reduces mortality and major morbidities: propensity score analysis of data from the Japan Cardiovascular Surgery Database†.
    Dohi M; Miyata H; Doi K; Okawa K; Motomura N; Takamoto S; Yaku H;
    Eur J Cardiothorac Surg; 2015 Feb; 47(2):299-307; discussion 307-8. PubMed ID: 24623172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of cardiovascular medical therapy among patients undergoing coronary artery bypass graft surgery: results from the ROSETTA-CABG registry.
    Okrainec K; Pilote L; Platt R; Eisenberg MJ
    Can J Cardiol; 2006 Aug; 22(10):841-7. PubMed ID: 16957801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.
    Zhang H; Yuan X; Zhang H; Chen S; Zhao Y; Hua K; Rao C; Wang W; Sun H; Hu S; Zheng Z
    Circulation; 2015 Jun; 131(25):2194-201. PubMed ID: 25908770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting.
    Ivens K; Gradaus F; Heering P; Schoebel FC; Klein M; Schulte HD; Strauer BE; Grabensee B
    Int Urol Nephrol; 2001; 32(4):717-23. PubMed ID: 11989572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of β-blocker therapy for secondary prevention for patients undergoing coronary artery bypass grafting surgery.
    Sun C; Zhang H; Zheng Z
    Curr Opin Cardiol; 2016 Nov; 31(6):654-661. PubMed ID: 27748695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the dynamics of depression symptoms on outcomes after coronary artery bypass grafting.
    Foss-Nieradko B; Stepnowska M; Piotrowicz R
    Kardiol Pol; 2012; 70(6):591-7. PubMed ID: 22718378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous postoperative insulin infusion reduces deep sternal wound infection in patients with diabetes undergoing coronary artery bypass grafting using bilateral internal mammary artery grafts: a propensity-matched analysis.
    Ogawa S; Okawa Y; Sawada K; Goto Y; Yamamoto M; Koyama Y; Baba H; Suzuki T
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):420-6. PubMed ID: 25825261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention.
    Hlatky MA; Solomon MD; Shilane D; Leong TK; Brindis R; Go AS
    J Am Coll Cardiol; 2013 Jan; 61(3):295-301. PubMed ID: 23246391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On-Pump Beating Heart Versus Conventional Coronary Artery Bypass Grafting Early After Myocardial Infarction: A Propensity-Score Matched Analysis From the ANZSCTS Database.
    Zhu MZL; Huq MM; Billah BM; Tran L; Reid CM; Varatharajah K; Rosenfeldt FL
    Heart Lung Circ; 2019 Aug; 28(8):1267-1276. PubMed ID: 30075944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention: Meds Matter: Impact of Adherence to Medical Therapy on Comparative Outcomes.
    Kurlansky P; Herbert M; Prince S; Mack M
    Circulation; 2016 Oct; 134(17):1238-1246. PubMed ID: 27777293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol.
    Khanderia U; Townsend KA; Eagle K; Prager R
    Chest; 2005 Feb; 127(2):455-63. PubMed ID: 15705982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Guideline-Directed Medical Therapy in Patients With ST-Elevation Myocardial Infarction.
    Latifi AN; Akram A; Dengle S; Minhas A; Borz-Baba C
    Cureus; 2020 Jul; 12(7):e9398. PubMed ID: 32864229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin Recapture Therapy before Coronary Artery Bypass Grafting Trial: Rationale and study design of a multicenter, randomized, double-blinded controlled clinical trial.
    Liakopoulos OJ; Kuhn EW; Hellmich M; Kuhr K; Krause P; Reuter H; Thurat M; Choi YH; Wahlers T;
    Am Heart J; 2015 Jul; 170(1):46-54, 54.e1-2. PubMed ID: 26093863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction.
    Foody JM; Ferdinand FD; Galusha D; Rathore SS; Masoudi FA; Havranek EP; Nilasena D; Radford MJ; Krumholz HM
    Circulation; 2003 Sep; 108 Suppl 1():II24-8. PubMed ID: 12970203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advantages of off-pump coronary bypass surgery over conventional coronary bypass surgery].
    Bordalo A; Nobre A; Mendes M; Pereira R; Lemos A; Pereira F; Serpa C; Cravino J
    Rev Port Cir Cardiotorac Vasc; 2010; 17(4):217-28. PubMed ID: 22611542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of Use of Statins and Aspirin in Patients With Previous Coronary Artery Bypass Grafting.
    Curl K; LeBude B; Ruggiero N; Fischman D; Rose A; Patel S; Ogilby D; Walinsky P; Jasti B; Savage M
    Am J Cardiol; 2016 Jul; 118(1):40-3. PubMed ID: 27178330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.
    Velazquez EJ; Lee KL; Jones RH; Al-Khalidi HR; Hill JA; Panza JA; Michler RE; Bonow RO; Doenst T; Petrie MC; Oh JK; She L; Moore VL; Desvigne-Nickens P; Sopko G; Rouleau JL;
    N Engl J Med; 2016 Apr; 374(16):1511-20. PubMed ID: 27040723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of Preoperative Use of Ticagrelor With or Without Aspirin Compared With Aspirin Alone in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Grafting.
    Gherli R; Mariscalco G; Dalén M; Onorati F; Perrotti A; Chocron S; Verhoye JP; Gulbins H; Reichart D; Svenarud P; Faggian G; Santarpino G; Fischlein T; Maselli D; Dominici C; Musumeci F; Rubino AS; Mignosa C; De Feo M; Bancone C; Gatti G; Maschietto L; Santini F; Nicolini F; Gherli T; Zanobini M; Kinnunen EM; Ruggieri VG; Rosato S; Biancari F
    JAMA Cardiol; 2016 Nov; 1(8):921-928. PubMed ID: 27653165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of cardiovascular event rate: different effects of cardiac rehabilitation in CABG and PCI patients.
    Hansen D; Dendale P; Leenders M; Berger J; Raskin A; Vaes J; Meeusen R
    Acta Cardiol; 2009 Oct; 64(5):639-44. PubMed ID: 20058510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The fate at mid-term follow-up of the on-pump vs. off-pump coronary artery bypass grafting surgery.
    Nardi P; Pellegrino A; Bassano C; Mani R; Chiariello GA; Zeitani J; Chiariello L
    J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):125-33. PubMed ID: 25022926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.